[Model for personalized diagnostics and treatment in neurology-German Academy for Rare Neurological Diseases].

Model für personalisierte Diagnostik und Therapie in der Neurologie – Deutsche Akademie für Seltene Neurologische Erkrankungen.

Journal

Der Nervenarzt
ISSN: 1433-0407
Titre abrégé: Nervenarzt
Pays: Germany
ID NLM: 0400773

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 28 6 2019
medline: 20 9 2019
entrez: 28 6 2019
Statut: ppublish

Résumé

The German Academy for Rare Neurological Diseases (DASNE) founded in 2017 on the Wartburg in Eisenach, aims to pave the way for an optimized personalized management of patients in all age groups with rare neurological diseases. By bringing rare neurological disease experts together and through forming a dynamic national network the DASNE, initiated by the Centers for Rare Diseases in Lübeck and Tübingen, will continuously foster mutual exchange. Members of the DASNE are renowned experts covering the whole spectrum of rare neurological disorders including pediatric neurology. Through case presentations and multidisciplinary discussion both at yearly meetings and on an internet platform, the main aims of DASNE are to establish a German expertise and reference network for rare neurological disorders. Further main aims are to provide continuous medical education for younger academics in the field of rare neurological disorders and facilitate translation.

Identifiants

pubmed: 31243508
doi: 10.1007/s00115-019-0750-2
pii: 10.1007/s00115-019-0750-2
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

796-803

Références

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):537-541
pubmed: 28275837
Orphanet J Rare Dis. 2017 Aug 7;12(1):137
pubmed: 28784158

Auteurs

Alexander Münchau (A)

Institut für Neurogenetik und Zentrum für Seltene Erkrankungen, Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Marie-Curie-Straße, 23562, Lübeck, Deutschland. alexander.muenchau@neuro.uni-luebeck.de.

Ludger Schöls (L)

Sektion Klinische Neurogenetik, Neurologische Klinik und Hertie Institut für Klinische Hirnforschung, Universität Tübingen, Tübingen, Deutschland.
Deutsches Zentrum für Neurodegenerative Erkrankungen, Tübingen, Deutschland.

Christine Klein (C)

Institut für Neurogenetik und Zentrum für Seltene Erkrankungen, Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Marie-Curie-Straße, 23562, Lübeck, Deutschland.

Holm Graessner (H)

Institut für Medizinische Genetik und angewandte Genomik und Zentrum für Seltene Erkrankungen, Universitätsklinikum und Universität Tübingen, Tübingen, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH